Revolutionising Treatment for Cataracts
VisusNano Ltd. is a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for laser treatment after surgery, our project has the potential to revolutionise cataract surgery in both the human and veterinary markets.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 12, 2018 | Grant | £20K | 1 | Accelerate@Babraham | — | Detail |
Mar 1, 2016 | Seed | — | 1 | Biostars | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Accelerate@Babraham | Yes | Grant |
Biostars | Yes | Seed |